CYP19A1 and cancer: CYP19A1 is critical for estrogen biosynthesis, thus, identifying genetic variants in CYP19A1 is necessary for assessing cancer risk and predicting response to aromatase inhibitor drugs across ethnically diverse and disparate populations.